Gold River Productions Inc (GRPS)

[D-Money6]

I re-read and find some of this verbiage from the Q2 financial informative as it relates to the road ahead. Nothing new here, discussing previous news.

The Company’s focus is on developing and acquiring businesses and products for health-related industries as alternatives to toxic pharmaceuticals. In that pursuit, the Company has been creating new and innovative products, cultivating distribution arrangements and manufacturing resources. In addition, the Company has acquired and intends to build schools with a focus on Autism. Able Academics will be a focus of new schools and nutraceutical and stem cell alternatives for these afflicted individuals.

Additionally, the company has entered into joint venture relationships with Able Academics Schools and Stemspa.

Additionally, for its products, it has formulated several outstanding distribution networks to include alternatives for physicians to offer our products to their patients as alternative to prescription and often toxic drugs.

Principal Products
The Company’s principal products have been formulated and produced. Our initial products focus on specific illnesses common to the mass market. Rare cannabinoids have been harnessed and used in sufficient quantity and in appropriate combinations to render efficacy: Relief Raspberry gummies, Calming Mango and Sleepy Watermelon have key formulations with an obvious purpose suggested in the name. These formulations are unique to the market and have been internally tested for efficacy. Furthermore, their safety is such that multiple gummies can be consumed without issues. These products were designed to work with our nutraceuticals, which alternatively have no CBD in their formulations. These nutraceutical compounds are produced after extensive Research and Development: Inflammaplex, EnergyPlex, and Painplex have amazing preliminary results in our internal anecdotal testing and work in conjunction with our gummies to relieve the issues internally.

Stem Cells is our latest acquisition. We have specific algorithms for appropriation and administration that we are delivering currently and will be presenting to the mass market shortly. We will be focusing on brick-and-mortar clinics, rendering stem cells to the lay physician and possibly developing off-shore locations for the administration of
these mostly umbilical-based products.

Distribution and Marketing
We have developed multiple channels of marketing and are not limiting our efforts to the United States alone, but have eyes on Mexico, Canada and South America as well as the surrounding Island nations. Our marketing will channel physicians, internet and retail facilities. We have teamed up with Virexit to initiate a novel internet marketing campaign that will essentially be a word-of-mouth campaign in digital format. We are currently working on more avenues of distribution and celebrity endorsements.

New Products - The specific products will not be named until they have been trademarked. Fortunately, we now have a facility for their creation. Eden Labs has been astounding in the attention to detail for the first formulations. They were charged with ethanol extraction of the proper portion of appropriate herbs in order to harness the most effective chemicals. This, in turn was reduced to powder after concentrating and placed into capsules. These formulations are expensive, but effective because of the chemistry behind them and the years of clinical knowledge that went into the creation. Our future formulations will be addressing: autism, memory, aging, chronic sleep
issues, libido and more. With anticipated funding, we look forward to completing the research and development of these products and mass produce them by the end of 2022.

Competitive Business Conditions
While our formulations cannot truly be protected, we have distinct advantages to the market from being the first out with our targeted products. Our nutraceuticals are being produced after over 20 companies were vetted and only one was able to produce them. Eden is under a non-disclosure agreement for our products. Unlike other nutraceuticals on the market, ours are formulated to have an instant effect without side-effects. Our Energyplex, for example, gives a noticeable burst of energy and focus without caffeine or sugar. Our Painplex formulation, works on other pathways than our Raspberry Relief gummy, so that the overall effect is very competitive to the opioid market for relief of discomfort.

Link to Financials - https://www.otcmarkets.com/otcapi/company/financial-report/298782/content

Few things to note that I noticed...
Monique Todd (Able) was given 30m shares in March 2020. Now they have moved to Cocoa, and opened up a clinic in Daytona and Tutoring in CA. Updated website with more personnel. After all, revenues from this arrangement are being presented on the financials, yet GRPS hasnt provided the funding yet.
https://ableacademics.com/

Info on the StemSpa front is quiet, but according to the financial notes above it is being worked on. Artin Babayan "purchased" 12.5m shares at .001 in March 2020. He is a real estate broker and loan officer in CA. Maybe he is helping find locations.

Not sure if this has been posted here yet, but saw StemSpa, Inc. is filed August 4th.
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=STEMSPA%20P210000703990&aggregateId=domp-p21000070399-7f506c25-b4c9-424a-8229-6ef3a3800c32&searchTerm=Stemspa%2C%20Inc.&listNameOrder=STEMSPA%20P210000703990

https://search.sunbiz.org/Inquiry/CorporationSearch/ConvertTiffToPDF?storagePath=COR%5C2021%5C0805%5C30116603.tif&documentNumber=P21000070399

If you take a look at Berkowitz' previous company, PacificStemCells, the website is no longer up. They got a letter from FDA about their marketing. On Berkowitz linked in, you can see his employment for PSC goes to August 2021.
http://pacificstemcells.com/
February+17,+2021+Untitled+Letter+-+Pacific+Stem+Cells+LLC.pdf
https://www.linkedin.com/in/mike-berkowitz-2354536/

On August 9, Dr. Bond tweeted this pic of RG presenting in front of Pacific Stem Cells presentation.
https://twitter.com/DrBruceBond/status/1424751557762064385



Lots coming down the pipeline between now and the end of 2022. Hold for Gold. Hold for paper.

Quarter 3 financials should be posted to OTC on or before 11/14.

$GRPS